Among the targeted genes are the key proapoptotic BAX (BCL2-associated X protein) [38], the caspases CASP3/8/9, and the cardinal player TP53 which are consistently upregulated in diverse cancer cell lines following treatment with natural compounds (Table 1). This evidence concerns the gene TP53 and cancer.